| Yomara Guanina Salcedo Santiago, EDD, CPL | |
|
813 Urb. Prado Alto, Barceloneta, PR 00617 | |
| (144) 341-0523 | |
| Not Available |
| Full Name | Yomara Guanina Salcedo Santiago |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 813 Urb. Prado Alto, Barceloneta, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538932611 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 1466 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Yomara Guanina Salcedo Santiago, EDD, CPL 813, Urb. Prado Alto, Barceloneta, PR 00617 Ph: (443) 410-5230 | Yomara Guanina Salcedo Santiago, EDD, CPL 813 Urb. Prado Alto, Barceloneta, PR 00617 Ph: (144) 341-0523 |
News Archive
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that the five-year follow-up of patients with high-risk malignancies from its Phase I/II clinical study confirms long-term safety and efficacy of ATIR™ over a broad dose range.
Seemingly overnight, healthy children develop mysterious, potentially disabling symptoms. When children finally receive a diagnosis, often after weeks of tests and office and hospital visits, the parents may be shocked to learn that they have multiple sclerosis - a potentially disabling autoimmune disease once believed to affect only adults.
The November 2010 issue of the Archives of Physical Medicine and Rehabilitation, Official Journal of the American Congress of Rehabilitation Medicine, has published a set of 9 articles on traumatic brain injury (TBI) that will accelerate future research in the field by establishing common language for the degree of injury, how it is measured and classified, treatment and potential outcomes.
Harvard Stem Cell Institute researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.
AMP-activated protein kinase, or AMPK, is a master regulator protein of metabolism that is conserved from yeast to humans. When a cell is low on fuel, AMPK shuts down processes that use energy and turns on processes that produce energy.Biologists have been studying how AMPK works for several decades and know that once it is activated, AMPK turns on a large number of genes by passing the "make more energy" message through numerous signaling cascades in the cell. What was not known, until now, was that AMPK also works via an epigenetic mechanism to slow down or stop cell growth.
› Verified 4 days ago
Mrs. Yanira Pizarro, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: Condominio Marina Iii, Apt. 802 C/ Ramon Marchand, Barceloneta, PR 00617 Phone: 178-790-4071 | |
Arnaldo Lopez, M.A L.P.C Counselor Medicare: Not Enrolled in Medicare Practice Location: 92 Urb Catalana Ste 2, Barceloneta, PR 00617 Phone: 939-400-8809 | |
Dr. Marie Torres, PH.D. Counselor Medicare: Medicare Enrolled Practice Location: Estancias De Barceloneta #253, Barceloneta, PR 00617 Phone: 787-920-4899 |